News

Medical Device Network on MSN4d
CEO maligns FDA delays over depression device treatments’ US market entry
Flow says approval delays persist for clinically validated depression devices, yet the US market is "flooded" with devices ...
UW-Madison center sees promise in using psychedelics for addiction, PTSD, depression
Far removed from the negative attention such drugs used to get, the hope is that they help people find answers within ...
Fierce Healthcare12d
Virtual depression and anxiety programs prove effective but costs vary wildly, PHTI finds
An independent analysis found virtual mental health solutions for depression and anxiety effectively treat the conditions, ...
The Heartland Institute5d
FDA to Phase Out Synthetic Food Dyes
The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) plan to phase out all ...
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
Financial News4d
NRx Pharmaceuticals (NASDAQ: NRXP) Announces $10.3M Financing to Expand HOPE Clinic Network, Advances FDA Drug Approval
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, is advancing its twin strategy of expanding a ...
FDA outlines stricter Covid vaccine booster approval standards for healthy people
The FDA recommended different standards of evidence for approval based on patients’ risk of getting severely sick from Covid.
FDA announces plans to restrict access for COVID vaccines
For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.